Evidence map›Paper›PMID 36730201›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Persistent binding at dopamine transporters determines sustained psychostimulant effects.

Marco Niello, Spyridon Sideromenos, Ralph Gradisch, Ronan O Shea, Jakob Schwazer, Julian Maier, Nina Kastner, Walter Sandtner, Kathrin Jäntsch, Carl R Lupica and 7 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 3 countries.

Marco NielloCenter for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-0518-5791
Spyridon SideromenosCenter for Physiology and Pharmacology, Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-5135-3346
Ralph GradischCenter for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-3312-2472
Ronan O SheaElectrophysiology Research Section, National Institute on Drug Abuse, NIH, Baltimore, MD 21224.
Jakob SchwazerCenter for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.
Julian MaierCenter for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.
Nina KastnerCenter for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-1576-9029
Walter SandtnerCenter for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.
Kathrin JäntschCenter for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.
Carl R LupicaElectrophysiology Research Section, National Institute on Drug Abuse, NIH, Baltimore, MD 21224.ORCID 0000-0002-5375-3263
Alexander F HoffmanElectrophysiology Research Section, National Institute on Drug Abuse, NIH, Baltimore, MD 21224.ORCID 0000-0002-2676-0628
Gert LubecDepartment of Neuroproteomics, Paracelsus Medical University, 5020 Salzburg, Austria.
Claus J LolandDepartment of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.ORCID 0000-0002-1773-1446
Thomas StocknerCenter for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-7071-8283
Daniela D PollakCenter for Physiology and Pharmacology, Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-9584-6257
Michael H BaumannDesigner Drug Research Unit, Intramural Research Program, National Institute on Drug Abuse, NIH, Baltimore, MD 21224.ORCID 0000-0001-7758-1470
Harald H SitteCenter for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-1339-7444
Medical University of Vienna · ATNational Institute on Drug Abuse · USParacelsus Medical University · ATUniversity of Copenhagen · DK

Funding

Preclinical medication development for stimulant use disorderZIADA000522 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI BAUMANN, MICHAEL · 2009 to 2025
$8.9M
Cocaine Addiction and the Role of Serotonin in Orbitofrontal Cortex FunctionZIADA000599 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI LUPICA, CARL · 2014 to 2025
$5.7M
Development of Dual Dopamine/Serotonin Releasing AgentsZ01DA000522 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI ROTHMAN, RICHARD · 2008 to 2008
$598k
Austrian Science Fund FWF DOC 33Austrian Science Fund FWF W 1232Intramural NIH HHS Z01 DA000522
6 · The paper itself

Abstract

Psychostimulants interacting with the dopamine transporter (DAT) can be used illicitly or for the treatment of specific neuropsychiatric disorders. However, they can also produce severe and persistent adverse events. Often, their pharmacological properties in vitro do not fully correlate to their pharmacological profile in vivo. Here, we investigated the pharmacological effects of enantiomers of pyrovalerone, α-pyrrolidinovalerophenone, and 3,4-methylenedioxypyrovalerone as compared to the traditional psychostimulants cocaine and methylphenidate, using a variety of in vitro, computational, and in vivo approaches. We found that in vitro drug-binding kinetics at DAT correlate with the time-course of in vivo psychostimulant action in mice. In particular, a slow dissociation (i.e., slow

Indexed as

Central Nervous System StimulantsCocaineMethylphenidateAnimalsDopamineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsMiceCentral Nervous System StimulantsCocaineDopamineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsMethylphenidatecathinonesdopamine transporterdrug-binding kineticsnew psychoactive substancespsychostimulants

Identifiers

PMID36730201
PMCPMC9963675
OpenAlexW4318917537

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.